What GDS-5 score is considered a positive depression screen?

A score of 2 or above is the standard positive screen threshold for GDS-5 (range 0-5). Published validation data report sensitivity of approximately 97% and specificity of 85% for major depression at this threshold, making it a highly sensitive screen.

What are the five items in GDS-5?

The most commonly used GDS-5 items (from the Hoyl validation) include: (1) Are you basically satisfied with your life? (2) Do you often get bored? (3) Do you often feel helpless? (4) Do you prefer to stay home rather than going out and doing things? (5) Do you feel pretty worthless the way you are now? Specific items vary slightly between validated versions.

GDS-5 was developed and validated by Hoyl and colleagues (1999) as an ultra-brief version of the Geriatric Depression Scale originally created by Yesavage et al. (1983). The 5-item version was derived by selecting items with highest individual sensitivity from the longer GDS-15.

How does GDS-5 compare to PHQ-2 for depression screening?

PHQ-2 uses 2 items (anhedonia and depressed mood) from PHQ-9. GDS-5 uses 5 items specifically selected for older adult populations. GDS-5 has higher sensitivity (97%) than PHQ-2 (approximately 83%) in older populations. PHQ-2 is faster; GDS-5 is more sensitive—choice depends on clinical context.

Can GDS-5 be self-completed by older adults?

Yes. GDS-5 can be self-completed by older adults with adequate literacy and cognitive function. For patients with low literacy, hearing impairment, or mild cognitive impairment, examiner-administered oral completion is preferred to ensure item comprehension.

Is GDS-5 appropriate for older adults from non-Western cultures?

Some GDS-5 items—particularly those about life satisfaction and staying home—may have different cultural resonance across ethnic and cultural groups. Translated and culturally adapted versions are preferable for non-English-speaking populations. Depression expression also varies culturally; somatic presenting complaints may be more common in some cultural groups.

Can GDS-5 track treatment response over time?

GDS-5 can be used serially to monitor treatment response, but its 5-point range limits sensitivity to change. GDS-15 or PHQ-9 are better suited to longitudinal treatment monitoring due to their larger score ranges and greater sensitivity to incremental symptom change.

What medical conditions commonly cause depression in older adults?

Common medical contributors to late-life depression include hypothyroidism, vitamin B12 and folate deficiency, chronic pain conditions, Parkinson's disease, stroke, cardiac disease, cancer, early dementia, and many medications (beta-blockers, corticosteroids, interferon, some antihypertensives). Excluding treatable causes before prescribing antidepressants is essential.

Is GDS-5 validated in care home residents?

Yes. GDS-5 has been used and validated in residential care home populations where depression prevalence is high (30-50%). In residents with moderate cognitive impairment, response reliability decreases. Observer-rated scales or combined approaches may improve accuracy in this group.

What should happen after a positive GDS-5 screen in primary care?

After a positive GDS-5: (1) Perform a full depression assessment with GDS-15 or PHQ-9, (2) assess suicide risk directly, (3) review medications for depressogenic effects, (4) check thyroid function, B12, folate, and FBC, (5) assess functional impact, (6) discuss treatment options—psychotherapy, antidepressants, or both—and (7) arrange follow-up within 2-4 weeks.

Does depression in older adults respond to antidepressant treatment?

Yes. Depression in older adults responds to antidepressant treatment, though response rates are somewhat lower and time to response longer than in younger populations. SSRIs (particularly sertraline and escitalopram) are first-line due to favorable tolerability profiles in older adults. Psychotherapy (CBT) has equivalent efficacy for mild to moderate depression.

Why is depression frequently missed in older adults?

Depression in older adults is underdiagnosed due to multiple factors: patients minimize or normalize symptoms as part of aging, somatic presentations may distract from mood symptoms, clinicians may have limited time for mood assessment, and the false belief that depression is a normal response to aging rather than a treatable condition persists. Routine screening with tools like GDS-5 systematically addresses this gap.

Online Medical Tools — GDS-5

Printed on 9/3/2026

For informational purposes only. This is not medical advice.

Geriatrics

GDS-5

The GDS-5 is a brief short form of the Geriatric Depression Scale designed for rapid mood screening in older adults. It uses yes/no responses and is commonly applied in geriatric primary care, long-term care, and memory-clinic workflows.

Formula: GDS-5 total = number of depressive-indicative responses (range 0-5).

GDS-5 total score

Save your results with a free account

Keep a history of calculations, favorite tools, and access your dashboard anytime.

Create free account Sign in

How It Works

Ask Five Yes/No Questions

The examiner reads five questions aloud or the patient self-completes them. Items assess: life satisfaction, reduction in activities and interests, emptiness and hopelessness, boredom, and spirits/mood. Each item is answered yes or no. The specific items vary slightly between the most widely cited GDS-5 validation versions.

Score Depressive Responses

Score 1 for each response indicative of depression (the direction varies by item—some score 'yes' as depressive, others score 'no'). Sum scores range 0-5. A score of 2 or above is the commonly used positive screen threshold (sensitivity approximately 97%, specificity 85% for major depression).

Determine Follow-Up Pathway

A positive GDS-5 screen (score 2+) should prompt full depression assessment using GDS-15, PHQ-9, or structured clinical interview. Assess suicide risk, medication contributors, medical causes of depression, and severity. Initiate treatment or refer appropriately—GDS-5 is the first step, not the final answer.

Who Uses the GDS-5

Ultra-Brief Primary Care Screening

General Practitioners & Family Physicians

GDS-5 provides a 1-2 minute depression screen for use in busy primary care when patient time is limited. It is particularly valuable in annual over-75 health checks, chronic disease reviews, and any consultation where depression might be a contributing but unacknowledged factor in presenting symptoms.

Acute Hospital Admission Screen

Hospital Medical & Nursing Teams

Depression in hospitalized older adults prolongs hospital stay, impairs rehabilitation, and increases mortality. GDS-5 at admission identifies patients who may benefit from psychiatry consultation, medication review, or psychosocial support during admission.

Residential Aged Care Monitoring

Aged Care Facility Staff

Depression prevalence in residential aged care is 30-50%. GDS-5 can be administered quarterly by care staff with basic training to identify residents with emerging depressive symptoms who may not spontaneously report mood changes.

Memory Clinic and Cognitive Assessment

Memory Clinic Teams

Depression is a common comorbidity and a reversible cause of apparent cognitive impairment (pseudodementia). GDS-5 administered alongside cognitive screens (MoCA, Mini-ACE) ensures that treatable depression is not missed as a potential explanation for cognitive test performance.

Cognitively Impaired Older Adults

Dementia Care Teams

GDS-5's yes/no format can be administered to patients with mild to moderate cognitive impairment who may not be able to complete longer scales. It captures the most accessible dimensions of subjective mood experience in people with early to moderate dementia.

Pro Tips

Adapt for Patients with Hearing Loss

Present items in large text format or provide a written version for patients with significant hearing impairment. Verbal administration with poor hearing can produce random response patterns that invalidate GDS-5 results. Always ensure hearing aids are in place and functioning.

Account for Physical Illness Overlap

GDS was specifically developed for older adults with the intentional exclusion of somatic symptoms (fatigue, appetite loss, sleep disturbance) that overlap with physical illness. This makes GDS-5 more depression-specific than PHQ-9 in medically ill older adults. However, questions about reduced activities and boredom may still reflect physical disability rather than depression.

Distinguish Grief from Clinical Depression

Older adults who have recently experienced bereavement may score positively on GDS-5 due to grief rather than clinical depression. Carefully explore whether symptoms are consistent with normal grief response before initiating antidepressant treatment. Prolonged or complicated grief requires specific intervention.

Repeat After Medical Stabilization

Depression screens performed during acute illness may overestimate depression prevalence due to symptom overlap and psychological adjustment to illness. Repeat GDS-5 4-6 weeks after medical stabilization to obtain a more accurate depression signal for treatment decision-making.

Always Ask About Suicide Risk After a Positive Screen

GDS-5 does not include a suicidality item. A positive screen should always be followed by a direct question about thoughts of self-harm or suicide: 'Do you ever have thoughts that life is not worth living, or thoughts of harming yourself?' Older adults have high suicide rates and are less likely to volunteer suicidal ideation spontaneously.

Use GDS-5 as a Gateway to GDS-15 or PHQ-9

When GDS-5 is positive, consider proceeding to GDS-15 for more detailed characterization of symptom profile before making treatment decisions. GDS-15 or PHQ-9 allow better tracking of treatment response over time and more granular symptom documentation.

Caregiver Observation Supplements Self-Report

Older adults with depression commonly minimize symptoms due to stigma or the perception that sadness is a normal part of aging. Briefly ask the caregiver or family member: 'Have you noticed any changes in mood, interest, or enjoyment of activities recently?' Caregiver-reported change often reveals depression that patients deny.

Consider Vascular Depression in Post-Stroke Patients

Depression following stroke is common and distinct from primary major depression. GDS-5 can identify post-stroke depression, but treatment response may differ—emphasize evidence-based post-stroke depression management and specialist neuropsychiatry referral for severe or treatment-resistant cases.

Common Questions About Your Results

Evidence-Based Methodology

GDS short forms have extensive validation in older-adult depression screening.

Clinical Content Trust

Last reviewed:: April 21, 2026
Guideline version:: General evidence framework v2026.04
Source set version:: Primary-source set v1

How to Interpret Your Result

Higher GDS-5 totals indicate greater depressive symptom burden and need for further assessment.

When to Use This Tool

Use for rapid depression triage in older adults, especially where brief screening is needed.

Limitations

Binary short-form items can miss symptom nuance; sensory/cognitive limitations may affect response reliability.

For related assessments, see GDS-15, PHQ-9 and HADS.

Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.

Sources

Changelog

April 21, 2026 · trust-baseline
Clinical trust metadata enabled for this tool page with structured review/version fields.

Related Tools

Mental Health